BadgerCare Plus and Medicaid SSI ProgramsSeptember 30, 2024
Carelon Medical Benefits Management, Inc. updates
Effective November 30, 2024
Effective on November 30, 2024, the following Carelon Medical Benefits Management, Inc. Clinical Appropriateness Guidelines updates will be adopted for Anthem. This article is to communicate the plan adoption of these Clinical Appropriateness Guidelines. Existing prior authorization requirements have not changed. In the event a prior authorization requirement or site of care review requirement for these services will be implemented, a separate notice will be distributed before the addition of any such prior authorization or site of care review requirement.
You may access and download a copy of the current and upcoming guidelines here.
- Genetic Testing:
- Cell-free DNA Testing for the Management of Cancer
- Prenatal Testing using cell-free DNA
- Somatic Tumor Testing
- Musculoskeletal:
- Small Joint Surgery
- Site of Care:
- Site of Care for Advanced Imaging
- Rehabilitative Site of Care
- Surgical Site of Care
The above guideline updates have a publish date of November 17, 2024.
Please share this notice with other members of your practice and office staff.
Anthem Blue Cross and Blue Shield is the trade name of Compcare Health Services Insurance Corporation. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
WIBCBS-CD-067240-24-CPN66675
PUBLICATIONS: November 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone